Ftse Mib
33.948,53
0,95%
DAX
18.160,29
0,93%
S&P 500
5.156,32
0,56%
NASDAQ
16.257,28
0,62%
Bitcoin
63.189,61
-1,26%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Canada TSX Medicenna Therapeutics Corp (MDNA) Medicenna Therapeutics Corp (MDNA) Notizie

Medicenna Therapeutics Corp

MDNA
2,45
0,06 (2,51%)
Ultimo aggiornamento: 16:55:50
Dati in Delay di 15 minuti
Borsa: Toronto
Tipo: Azione
Valuta: CAD

Ultime notizie

Data Ora Fonte Titolo
30/4/202417:07GLOBEMedicenna Therapeutics Announces Closing of CA$20 Million..
26/4/202414:16PRNCAL'Organisme canadien de réglementation des investissements..
26/4/202414:14PRNCACanadian Investment Regulatory Organization Trade Resumption..
26/4/202414:09PRNCASuspension de la négociation par l'Organisme canadien de..
26/4/202414:07PRNCACanadian Investment Regulatory Organization Trading Halt -..
26/4/202414:00GLOBEMedicenna Therapeutics Announces CA$20 Million Investment..
24/4/202416:05GLOBEMedicenna Announces Oral Presentation of MDNA11 Data from..
10/4/202412:30GLOBEMedicenna Presents Updated Results of Single Agent MDNA11..
09/4/202422:30GLOBEMedicenna Presents Updated Results of Single Agent MDNA11..
09/4/202418:01GLOBEMedicenna Presents Updated Preclinical Data on MDNA113, a..
04/4/202413:00GLOBEMedicenna to Present at the 2024 Bloom Burton & Co...
06/3/202413:00GLOBEMedicenna to Provide Clinical Update on the MDNA11 ABILITY-1..
14/2/202413:30GLOBEMedicenna Therapeutics Reports Third Quarter Fiscal 2024..
13/2/202413:00GLOBEMedicenna Announces First Patient Dosed in ABILITY-1 Study..
12/1/202423:36GLOBEMedicenna Announces Appointment of New Auditor
09/1/202413:00GLOBEMedicenna Commences Enrollment in the ABILITY-1 Study..
22/12/202301:30GLOBEMedicenna Extends Period to Exercise Certain Warrants
19/12/202313:00GLOBEMedicenna Announces Trading on the OTCQB Under the Symbol..
14/11/202314:30GLOBEMedicenna Therapeutics Reports Second Quarter Fiscal 2024..
09/11/202314:56GLOBEMedicenna to Present 4 Year Follow-up Phase 2b Bizaxofusp..
06/11/202313:00GLOBEMedicenna Announces Promising Single-Agent Response and..
03/11/202317:00GLOBEMedicenna Presents Preclinical Data on MDNA113, its Targeted..
27/10/202313:55GLOBEMedicenna Announces Nasdaq Delisting and Cutback of..
25/10/202313:00GLOBEMedicenna Therapeutics Doses First Patient in Phase 2..
24/10/202313:15GLOBEMedicenna Announces Presentations at the 38th Annual Meeting..
10/10/202313:07GLOBEMedicenna Therapeutics Appoints Humphrey Gardner, M.D., as..
03/10/202313:00GLOBEMedicenna Presents Preclinical MDNA223 BiSKIT Data at the..
28/9/202323:00GLOBEMedicenna Announces Results of Annual and Special Meeting of..
28/9/202313:00GLOBEMedicenna to Present at the AACR Special Conference Cancer..
06/9/202313:00GLOBEMedicenna to Participate at The H.C. Wainwright 25th Annual..
28/8/202313:00GLOBEMedicenna Announces the Appointment of Jeff Caravella as..
14/8/202313:00GLOBEMedicenna Establishes Boston Presence, Appoints Brent..
08/8/202313:00GLOBEMedicenna Appoints Dr. Arash Yavari as Chair of Development..
04/8/202313:00GLOBEMedicenna Therapeutics to Provide Clinical Update from Phase..
01/8/202315:30GLOBEMedicenna Strengthens IP Portfolio with U.S. Patent Granted..
28/7/202313:00GLOBEMedicenna Reports First Quarter Fiscal 2024 Financial..
25/7/202313:00GLOBEMedicenna Presents at National Brain Tumor Society's..
05/7/202313:00GLOBEMedicenna Extends Period to Exercise Certain Warrants
27/6/202314:00GLOBEMedicenna Reports Fiscal Year 2023 Financial Results and..
Apertura: 2,39 Min: 2,39 Max: 2,49
Chiusura: 2,39

La tua Cronologia

TSX
MDNA
Medicenna Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network